4//SEC Filing
Stuart Nancy 4
Accession 0001209191-22-005886
CIK 0001367920other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:06 PM ET
Size
7.2 KB
Accession
0001209191-22-005886
Insider Transaction Report
Form 4
Stuart Nancy
Chief Operating Officer10% Owner
Transactions
- Award
Common Stock
2022-01-28+21,400→ 290,786 total - Award
Common Stock
2022-01-28+99,000→ 269,386 total
Footnotes (3)
- [F1]Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in equal annual installments over a three-year period measured from the date of grant. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant.
- [F2]Not applicable.
- [F3]Represents a grant of RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest one business day after the date on which the Food and Drug Administration notifies the Issuer that it has accepted for filing a New Drug Application for CTP-543, provided that the date of acceptance is on or before a certain date in 2023. The amount listed represents the maximum number of shares that may be delivered pursuant to the grant.
Documents
Issuer
CONCERT PHARMACEUTICALS, INC.
CIK 0001367920
Entity typeother
Related Parties
1- filerCIK 0001594774
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 4:06 PM ET
- Size
- 7.2 KB